WHO ICTRP trial
A Phase 2, Randomized, Open Label Study to Evaluate the Efficacy and Safety of…
ACTRN12616000898459 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12616000898459 |
|---|---|
| Public title | A Phase 2, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF)–containing Regimens in Subjects with Chronic Hepatitis B (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant |
| Scientific title | A Phase 2, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF)–containing Regimens in Subjects with Chronic HBV Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant |
| Primary sponsor | Gilead Sciences, Inc. |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | New Zealand |
| Conditions | Chronic Hepatitis B;Chronic Kidney Disease; Chronic Hepatitis B Chronic Kidney Disease;Infection - Other infectious diseases;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and… |
| Interventions | Approximately 60 subjects with chronic hepatitis B and Stage 2 or greater chronic kidney disease and have received a liver transplant will be assigned to one of the two treatment arms (A:B) for 48 weeks. Randomization will be stratified by… |
| Registration date | Jul 7, 2016 |
| Target size | 50 |
| Secondary IDs | GS-US-320-3912 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: